Despite regulatory uncertainties and the lack of safety data, companies are rushing nanomaterials to market in a wide variety of FDA-regulated product
categories. A public inventory of products that claim to contain nanomaterials includes products such as foods (including dietary supplements), food
packaging and other food contact products, cosmetics, devices and drugs.

Food and food contact products listed in the inventory include oils, tea, nutritional and sports supplements, food storage containers, plastic wrap and
kitchenware. Some of these products are claimed to help control weight, slow aging, reduce viral loads or destroy bacteria. The inventory includes a
number of cosmetic products (77) and sunscreen products (27), as well as products classified as “personal care” products that include toothpaste, wound
dressings, pregnancy tests, hearing aids, antiseptic sprays for cuts and scrapes, and pain relief products.

Although products such as foods and cosmetics generally are not subject to premarket approval, political and regulatory pressures may yet be brought to
bear on nanotechnology as more information is gathered about possible toxicological, human health, and environmental effects of nanomaterials.
This article suggests a number of risk mitigation strategies broadly applicable to the manufacture of all FDA-regulated products that contain
nanomaterials.

Download the .PDF to read the full article.

Linked files

Risk Mitigation Strategies For Manufacturers of Nanomaterials [242kb]